share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Newman James W. Jr.

SEC ·  Mar 28, 2024 06:25

Summary by Moomoo AI

James W. Newman Jr., a reporting person for Adial Pharmaceuticals, Inc. (ADIL), has engaged in a transaction involving the company's stock. The action took place on March 25, 2024. However, the announcement did not disclose the nature of the transaction, including the action type, status, number of shares involved, transaction price, or the resulting number of shares held after the action. Without these details, the total value of the shares cannot be determined. The relationship of Newman to the issuer was also not specified in the provided information.
James W. Newman Jr., a reporting person for Adial Pharmaceuticals, Inc. (ADIL), has engaged in a transaction involving the company's stock. The action took place on March 25, 2024. However, the announcement did not disclose the nature of the transaction, including the action type, status, number of shares involved, transaction price, or the resulting number of shares held after the action. Without these details, the total value of the shares cannot be determined. The relationship of Newman to the issuer was also not specified in the provided information.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Hoth Therapeutics
    HOTH
    -- 2.2800
    Sol-Gel Technologies
    SLGL
    -- 1.400
    NRX Pharmaceuticals
    NRXP
    -- 4.6600
    Matinas BioPharma
    MTNB
    -- 0.9598
    Eyenovia
    EYEN
    -- 0.157

    Unlock the Full List